SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-019547
Filing Date
2021-08-12
Accepted
2021-08-12 08:30:23
Documents
14
Period of Report
2021-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 noticker-20210812.htm   iXBRL 8-K 27861
2 ex_274966.htm EX-99.1 96895
  Complete submission text file 0001437749-21-019547.txt   287519

Data Files

Seq Description Document Type Size
3 noticker-20210812.xsd EX-101.SCH 4091
4 noticker-20210812_def.xml EX-101.DEF 13861
5 noticker-20210812_lab.xml EX-101.LAB 18224
6 noticker-20210812_pre.xml EX-101.PRE 13887
7 EXTRACTED XBRL INSTANCE DOCUMENT noticker-20210812_htm.xml XML 4449
Mailing Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070
Business Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 211165596
SIC: 2836 Biological Products, (No Diagnostic Substances)